OPPM
JUNO

Opus Point Partners Management’s Juno Therapeutics, Inc. JUNO Stock Holding History

Opus Point Partners Management’s Portfolio JUNO Stock Details JUNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-50
Closed -$49K – 64
2015
Q2 		$49K Buy
+50
New +$2.65K 0.04% 56

Other funds holding JUNO

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Opus Point Partners Management's JUNO Position: Q1 2018 in Review

Opus Point Partners Management sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 5,588 shares — an estimated $255K sold.

Opus Point Partners Management first reported a position in JUNO in Q2 2015 and held it in 7 quarters. The position peaked at $660K in Q3 2017. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

  • Opus Point Partners Management reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
  • Opus Point Partners Management sold 5,588 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $255K.
  • Opus Point Partners Management first reported a position in Juno Therapeutics, Inc. in Q2 2015 and held it in 7 quarters.
  • Opus Point Partners Management's Juno Therapeutics, Inc. position peaked at $660K in Q3 2017.
  • 2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on Opus Point Partners Management's 13F filing for Q1 2018, filed 15 May 2018.